Yves J L Bodar

7PUBLICATIONS
11CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 24, 2023
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.

Yves J L Bodar, Liselotte M S Boevé, Pim J van Leeuwen

|Sep 19, 2022
The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.

Hans Veerman, Maarten Donswijk, Elise Bekers

|Feb 15, 2022
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.

Yves J L Bodar, Hans Veerman, Dennie Meijer

|Dec 02, 2021
The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.

Hans Veerman, Maarten Donswijk, Elise Bekers

|Nov 02, 2021
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.

Yves J L Bodar, Ben G J C Zwezerijnen, Patrick J van der Voorn

|Oct 20, 2020
Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial.

Y J L Bodar, B H E Jansen, J P van der Voorn

Pageof 2

Frequent Collaborators

3 joint publications

Hans Veerman

3 joint publications

Dennie Meijer

2 joint publications

Henk G van der Poel

1 joint publications

B H E Jansen